$1,000 – $3,000 Paid Clinical Trials

440 studies

Standard inpatient Phase 1 studies with multi-day residential stays typically compensate $1,000–$3,000.

Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.

Showing 81–100 of 440 studies

$1,000 – $3,000 Paid Clinical Trials

Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity

A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM

A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.

A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nascertib Moves Through the Body In Healthy Adult Japanese Participants

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants

A Study of LAD106 in Healthy Adult Participants

A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

A Study of Mirikizumab Solution (LY3074828) in Healthy Participants

A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

A Phase 1 Study of Navlimetostat Tablet Formulations

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants

A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes